C反應蛋白檢測全球市場報告（2026年）

近年來，C反應蛋白檢測市場顯著擴張，預計將從2025年的35.2億美元成長到2026年的37億美元，複合年成長率為5.1%。過去幾年的成長可歸因於多種因素，例如炎症性疾病患病率的上升、CRP檢測在臨床診斷中應用日益廣泛、醫院檢查室基礎設施的擴建、人們對疾病早期檢測意識提升以及標準化檢測套組的廣泛使用。

預計未來幾年C反應蛋白（CRP）檢測市場將穩定成長，到2030年市場規模將達到44.8億美元，複合年成長率（CAGR）為4.9%。預測期內的成長要素包括：照護現場發炎檢測需求不斷成長、自動化診斷平台整合程度不斷提高、預防性健康篩檢範圍擴大、高通量檢測系統應用日益廣泛以及對個人化醫療診斷的日益重視。預測期內的主要趨勢包括：高靈敏度CRP檢測法的應用日益普及、自動化免疫檢測系統使用率不斷提高、對快速發炎診斷的需求不斷成長、CRP檢測在心血管風險評估中的應用範圍擴大以及對檢查室工作流程自動化的日益重視。

心血管疾病（CVD）發生率的不斷上升預計將推動C反應蛋白檢測市場的成長。心血管疾病包括血管疾病、結構性問題和血栓等心臟疾病。雖然心血管疾病的確切病因尚未完全明確，但多種因素會增加罹病風險。其中一個關鍵因素是行為風險，例如不良飲食、缺乏運動、吸煙和飲酒。這些因素會促進動脈內脂肪沉積（動脈粥狀硬化），並增加血栓形成的風險。這些行為風險也會導致高血壓、高血糖、高血脂症、體重增加和肥胖。隨著心血管疾病發生率的上升，人們對C反應蛋白檢測的需求（類似膽固醇檢測）也不斷成長，以用於心血管疾病的診斷和預測。例如，根據健康指標與評估研究所 (IHME) 於 2023 年 12 月發布的報告，2022 年全球心血管疾病死亡人數將達到 1,980 萬，缺血性心臟疾病死亡率將達到每 10 萬人 108.8 人。收縮期高血壓是導致心血管疾病相關失能調整後存活年(DALY) 的主要因素，而飲食風險和空氣污染正成為加劇此全球性挑戰的重要行為和環境因素。

C反應蛋白 (CRP) 檢測市場的主要企業正致力於技術創新，例如高靈敏度自動化免疫檢測，該方法能夠更準確、快速地檢測低濃度CRP，從而支持早期心血管風險評估和即時發炎監測。高靈敏度自動化免疫檢測分析法採用改良的免疫濁度或散射比濁法技術，能夠檢測到遠低於標準檢測法的CRP濃度，從而實現早期療育和更佳的預後。 2024年1月，總部位於德國的體外診斷公司西門子醫療宣布推出適用於其Atellica CH分析儀的Atellica CH高靈敏度C反應蛋白2 (hCRP2) 檢測系統。該系統使用兩個即用型試劑盒，透過測量CRP顆粒凝集引起的光散射來檢測CRP。它能夠快速提供血清或血漿檢體的定量結果，從而支持及時的臨床決策。

目錄

第1章執行摘要

第2章 市場特徵

• 市場定義和範圍
• 市場區隔
• 主要產品和服務概述
• 全球C反應蛋白檢測市場：吸引力評分及分析
• 成長潛力分析、競爭評估、策略契合度評估、風險狀況評估

第3章 市場供應鏈分析

• 供應鏈與生態系概述
• 主要原料、資源和供應商清單
• 主要經銷商和通路合作夥伴名單
• 主要最終用戶列表

第4章 全球市場趨勢與策略

• 關鍵技術和未來趨勢
  • 生物技術、基因組學和精準醫學
  • 數位化、雲端運算、巨量資料、網路安全
  • 工業4.0和智慧製造
  • 人工智慧（AI）和自主人工智慧
  • 物聯網、智慧基礎設施和互聯生態系統
• 主要趨勢
  • 擴大高靈敏度CRP檢測法的應用
  • 擴大自動化免疫檢測系統的應用
  • 對快速發炎診斷的需求日益成長
  • 擴大CRP檢測在心血管風險評估的應用
  • 日益關注檢查室工作流程自動化

第5章 終端用戶產業市場分析

• 醫院
• 診斷檢查室
• 診所
• 專業醫療中心
• 研究所

第6章 市場：宏觀經濟情景，包括利率、通貨膨脹、地緣政治、貿易戰和關稅的影響、關稅戰和貿易保護主義對供應鏈的影響，以及新冠疫情對市場的影響

第7章 全球策略分析架構、目前市場規模、市場對比及成長率分析

• 全球C反應蛋白檢測市場：PESTEL分析（政治、社會、技術、環境、法律因素、促進因素與限制因素）
• 全球C反應蛋白檢測市場規模、對比及成長率分析
• 全球C反應蛋白檢測市場表現：規模與成長，2020-2025年
• 全球C反應蛋白檢測市場預測：規模與成長，2025-2030年，2035年預測

第8章 全球潛在市場規模（TAM）

第9章 市場細分

• 按檢測類型
• 酵素免疫分析法(ELISA)、化學冷光免疫檢測分析 (CLIA)、免疫比濁檢測法
• 透過使用
• 糖尿病、類風濕性關節炎、心血管疾病、發炎性腸道疾病、癌症及其他用途
• 按最終用途
• 診所、醫院和診斷檢查室
• 按類型細分：酵素免疫分析法試驗 (ELISA)
• 直接ELISA、間接ELISA、夾心ELISA
• 按類型細分：化學冷光免疫檢測(CLIA)
• 基於發光儀的化學發光免疫分析法（CLIA），自動化化學發光免疫分析系統
• 依類型細分：檢測法
• 基於濁度法的檢測法濁法，乳膠凝集檢測法

第10章 區域與國家分析

• 全球C反應蛋白檢測市場：依地區、績效及預測分類，2020-2025年、2025-2030年預測、2035年預測
• 全球C反應蛋白檢測市場：依國家、績效及預測分類，2020-2025年、2025-2030年預測、2035年預測

第11章 亞太市場

第12章：中國市場

第13章 印度市場

第14章 日本市場

第15章：澳洲市場

第16章 印尼市場

第17章 韓國市場

第18章 台灣市場

第19章 東南亞市場

第20章：西歐市場

第21章英國市場

第22章 德國市場

第23章：法國市場

第24章：義大利市場

第25章：西班牙市場

第26章 東歐市場

第27章：俄羅斯市場

第28章 北美市場

第29章：美國市場

第30章：加拿大市場

第31章 南美洲市場

第32章：巴西市場

第33章 中東市場

第34章：非洲市場

第35章 市場監理與投資環境

第36章：競爭格局與公司概況

• C反應蛋白檢測市場：競爭格局及市場佔有率（2024年）
• C反應蛋白檢測市場：公司估值矩陣
• C反應蛋白檢測市場：公司概況
  • Thermo Fisher Scientific Inc.
  • F Hoffmann-La Roche AG
  • Danaher Corporation
  • Quest Diagnostics Incorporated
  • Siemens AG

第37章：其他領先和創新企業

• Abbott Laboratories, Aidian Oy, Boditech Med Inc., Horiba Ltd., Laboratory Corporation, Merck KGAA, Randox Laboratories Limited, Getein Biotech Inc., Bio-Rad Laboratories Inc., DiaSorin SpA, Eurofins Scientific SE, Inova Diagnostics Inc., Luminex Corporation, Sekisui Diagnostics LLC, Sysmex Corporation

第38章 全球市場競爭基準分析與儀錶板

第39章 重大併購

第40章：高潛力市場國家、細分市場與策略

• 2030年C反應蛋白檢測市場：提供新機會的國家
• C反應蛋白檢測市場展望（2030）：新興細分市場機會
• C反應蛋白檢測市場2030年：成長策略
  • 基於市場趨勢的策略
  • 競爭對手策略

第41章附錄

C-reactive protein (CRP) testing is a diagnostic procedure that assesses the concentration of CRP in the bloodstream, a protein produced by the liver in response to inflammation. In cases of injury or infection, the body initiates inflammation as a protective mechanism. CRP testing is primarily employed to identify inflammation resulting from infections.

The primary assay methods utilized in the CRP testing market include enzyme-linked immunosorbent assay (ELISA), chemiluminescence immunoassay (CLIA), and immunoturbidimetric assays. ELISA, for instance, is a technique employed to quantitatively measure human CRP levels in serum, aiding in the monitoring of conditions such as rheumatic fever and inflammatory processes. ELISA serves as a biological assay focusing on the measurement of antibodies, antigens, proteins, and glycoproteins. CRP testing is widely applied in clinical settings, hospitals, and diagnostic laboratories, contributing to the diagnosis and monitoring of various conditions such as diabetes, rheumatoid arthritis, cardiovascular diseases, inflammatory bowel disease, cancer, and others.

Tariffs are influencing the c-reactive protein testing market by increasing costs of imported reagents, assay kits, analyzers, and diagnostic instrumentation used across elisa, clia, and immunoturbidimetric platforms. Diagnostic laboratories and hospitals in North America and Europe are most affected due to reliance on imported testing systems, while Asia-Pacific faces cost pressures on reagent supply chains. These tariffs are raising operational costs and impacting test pricing. At the same time, they are encouraging local reagent manufacturing, regional analyzer assembly, and domestic diagnostic technology development.

The c-reactive protein testing market research report is one of a series of new reports from The Business Research Company that provides c-reactive protein testing market statistics, including c-reactive protein testing industry global market size, regional shares, competitors with a c-reactive protein testing market share, detailed c-reactive protein testing market segments, market trends and opportunities, and any further data you may need to thrive in the c-reactive protein testing industry. This c-reactive protein testing market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The c-reactive protein testing market size has grown strongly in recent years. It will grow from $3.52 billion in 2025 to $3.7 billion in 2026 at a compound annual growth rate (CAGR) of 5.1%. The growth in the historic period can be attributed to increasing prevalence of inflammatory diseases, rising use of crp testing in clinical diagnostics, expansion of hospital laboratory infrastructure, growing awareness of early disease detection, availability of standardized assay kits.

The c-reactive protein testing market size is expected to see steady growth in the next few years. It will grow to $4.48 billion in 2030 at a compound annual growth rate (CAGR) of 4.9%. The growth in the forecast period can be attributed to increasing demand for point-of-care inflammatory testing, rising integration of automated diagnostics platforms, expansion of preventive healthcare screening, growing adoption of high-throughput laboratory systems, increasing focus on personalized medicine diagnostics. Major trends in the forecast period include increasing adoption of high-sensitivity crp assays, rising use of automated immunoassay systems, growing demand for rapid inflammation diagnostics, expansion of crp testing in cardiovascular risk assessment, enhanced focus on laboratory workflow automation.

The rise in cardiovascular disease (CVD) cases is expected to drive the growth of the C-reactive protein testing market. Cardiovascular diseases encompass heart conditions such as diseased vessels, structural issues, and blood clots. While the exact cause of CVD is not fully understood, several factors can increase the risk of developing it. One significant factor is behavioral risk, stemming from poor diet, insufficient physical activity, smoking, and alcohol consumption, which leads to the buildup of fatty deposits in the arteries (atherosclerosis) and heightens the risk of blood clots. These behavioral risks contribute to elevated blood pressure, glucose levels, blood lipids, weight gain, and obesity. As CVD cases rise, there is an increasing demand for C-reactive protein testing to diagnose or predict the likelihood of cardiovascular issues, similar to cholesterol testing. For example, in December 2023, the Institute for Health Metrics and Evaluation reported that global deaths from cardiovascular diseases reached 19.8 million in 2022, with ischemic heart disease accounting for 108.8 deaths per 100,000 people. High systolic blood pressure was the leading contributor to disability-adjusted life years (DALYs) associated with CVD, while dietary risks and air pollution emerged as significant behavioral and environmental factors exacerbating this global issue.

Major players in the C-Reactive Protein testing market are focusing on technological advancements such as high-sensitivity automated immunoassays for more accurate, rapid, and low-level CRP detection, supporting early cardiovascular risk assessment and real-time inflammation monitoring. High-sensitivity automated immunoassays use refined immunoturbidimetric or nephelometric techniques to detect CRP levels far below standard assays, enabling earlier intervention and improved prognostic evaluation. In January 2024, Siemens Healthineers, a Germany-based in vitro diagnostics company, launched the Atellica CH High Sensitivity C-Reactive Protein 2 (hCRP2) assay for its Atellica CH Analyzer. The system uses two ready-to-use reagent packs and measures light scattering caused by CRP-induced particle aggregation, providing rapid, quantitative results compatible with serum or plasma samples for timely clinical decision-making.

In July 2024, Roche, a Switzerland-based diagnostics company, acquired LumiraDx's point-of-care platform for an undisclosed amount. Through this acquisition, Roche seeks to enhance its CRP testing capabilities by incorporating LumiraDx's rapid, quantitative CRP assay into its diagnostics portfolio and expanding access to point-of-care immunoassays. LumiraDx is a UK-based company that offers a multi-assay point-of-care platform, including a microfluidic immunoassay for quantitative C-Reactive Protein testing.

Major companies operating in the c-reactive protein testing market are Thermo Fisher Scientific Inc., F Hoffmann-La Roche AG, Danaher Corporation, Quest Diagnostics Incorporated, Siemens AG, Abbott Laboratories, Aidian Oy, Boditech Med Inc., Horiba Ltd., Laboratory Corporation, Merck KGAA, Randox Laboratories Limited, Getein Biotech Inc., Bio-Rad Laboratories Inc., DiaSorin S.p.A., Eurofins Scientific SE, Inova Diagnostics Inc., Luminex Corporation, Sekisui Diagnostics LLC, Sysmex Corporation, Tosoh Corporation, Trinity Biotech Plc, WerfenLife Group LLC, ZEUS Scientific Inc., BioMerieux SA, Biomerica Inc., Gold Standard Diagnostics Corp., Immunodiagnostic Systems Holdings PLC, Nova Biomedical Corporation

North America was the largest region in the c-reactive protein testing market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the c-reactive protein testing market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the c-reactive protein testing market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain

The c-reactive protein testing market includes revenues earned by entities by devices and reagents. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

C-Reactive Protein Testing Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses c-reactive protein testing market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
• Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on end user analysis.
• Benchmark performance against key competitors based on market share, innovation, and brand strength.
• Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
• Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for c-reactive protein testing ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The c-reactive protein testing market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
• The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
• The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
• The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
• The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
• The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
• Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.

Scope

• Markets Covered:1) By Assay Type: Enzyme-Linked Immunosorbent Assay (ELISA); Chemiluminescence Immunoassay (CLIA); Immunoturbidimetric Assays
• 2) By Application: Diabetes; Rheumatoid Arthritis; Cardiovascular Disease; Inflammatory Bowel Disease; Cancer; Other Applications
• 3) By End Use: Clinics; Hospitals; Diagnostic Laboratories
• Subsegments:
• 1) By Enzyme-Linked Immunosorbent Assay (ELISA): Direct ELISA; Indirect ELISA; Sandwich ELISA
• 2) By Chemiluminescence Immunoassay (CLIA): Luminometer-Based CLIA; Automated CLIA Systems
• 3) By Immunoturbidimetric Assays: Nephelometry-Based Immunoturbidimetric Assays; Latex Agglutination Immunoturbidimetric Assays
• Companies Mentioned: Thermo Fisher Scientific Inc.; F Hoffmann-La Roche AG; Danaher Corporation; Quest Diagnostics Incorporated; Siemens AG; Abbott Laboratories; Aidian Oy; Boditech Med Inc.; Horiba Ltd.; Laboratory Corporation; Merck KGAA; Randox Laboratories Limited; Getein Biotech Inc.; Bio-Rad Laboratories Inc.; DiaSorin S.p.A.; Eurofins Scientific SE; Inova Diagnostics Inc.; Luminex Corporation; Sekisui Diagnostics LLC; Sysmex Corporation; Tosoh Corporation; Trinity Biotech Plc; WerfenLife Group LLC; ZEUS Scientific Inc.; BioMerieux SA; Biomerica Inc.; Gold Standard Diagnostics Corp.; Immunodiagnostic Systems Holdings PLC; Nova Biomedical Corporation
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time Series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery Format: Word, PDF or Interactive Report
• + Excel Dashboard
• Added Benefits
• Bi-Annual Data Update
• Customisation
• Expert Consultant Support

Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.

Table of Contents

1. Executive Summary

• 1.1. Key Market Insights (2020-2035)
• 1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots
• 1.3. Major Factors Driving the Market
• 1.4. Top Three Trends Shaping the Market

2. C-Reactive Protein Testing Market Characteristics

• 2.1. Market Definition & Scope
• 2.2. Market Segmentations
• 2.3. Overview of Key Products and Services
• 2.4. Global C-Reactive Protein Testing Market Attractiveness Scoring And Analysis
  • 2.4.1. Overview of Market Attractiveness Framework
  • 2.4.2. Quantitative Scoring Methodology
  • 2.4.3. Factor-Wise Evaluation
• Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation
• 2.4.4. Market Attractiveness Scoring and Interpretation
• 2.4.5. Strategic Implications and Recommendations

3. C-Reactive Protein Testing Market Supply Chain Analysis

• 3.1. Overview of the Supply Chain and Ecosystem
• 3.2. List Of Key Raw Materials, Resources & Suppliers
• 3.3. List Of Major Distributors and Channel Partners
• 3.4. List Of Major End Users

4. Global C-Reactive Protein Testing Market Trends And Strategies

• 4.1. Key Technologies & Future Trends
  • 4.1.1 Biotechnology, Genomics & Precision Medicine
  • 4.1.2 Digitalization, Cloud, Big Data & Cybersecurity
  • 4.1.3 Industry 4.0 & Intelligent Manufacturing
  • 4.1.4 Artificial Intelligence & Autonomous Intelligence
  • 4.1.5 Internet Of Things (Iot), Smart Infrastructure & Connected Ecosystems
• 4.2. Major Trends
  • 4.2.1 Increasing Adoption Of High-Sensitivity Crp Assays
  • 4.2.2 Rising Use Of Automated Immunoassay Systems
  • 4.2.3 Growing Demand For Rapid Inflammation Diagnostics
  • 4.2.4 Expansion Of Crp Testing In Cardiovascular Risk Assessment
  • 4.2.5 Enhanced Focus On Laboratory Workflow Automation

5. C-Reactive Protein Testing Market Analysis Of End Use Industries

• 5.1 Hospitals
• 5.2 Diagnostic Laboratories
• 5.3 Clinics
• 5.4 Specialty Care Centers
• 5.5 Research Laboratories

6. C-Reactive Protein Testing Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global C-Reactive Protein Testing Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

• 7.1. Global C-Reactive Protein Testing PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 7.2. Global C-Reactive Protein Testing Market Size, Comparisons And Growth Rate Analysis
• 7.3. Global C-Reactive Protein Testing Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)
• 7.4. Global C-Reactive Protein Testing Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global C-Reactive Protein Testing Total Addressable Market (TAM) Analysis for the Market

• 8.1. Definition and Scope of Total Addressable Market (TAM)
• 8.2. Methodology and Assumptions
• 8.3. Global Total Addressable Market (TAM) Estimation
• 8.4. TAM vs. Current Market Size Analysis
• 8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. C-Reactive Protein Testing Market Segmentation

• 9.1. Global C-Reactive Protein Testing Market, Segmentation By Assay Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Enzyme-Linked Immunosorbent Assay (ELISA), Chemiluminescence Immunoassay (CLIA), Immunoturbidimetric Assays
• 9.2. Global C-Reactive Protein Testing Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Diabetes, Rheumatoid Arthritis, Cardiovascular Disease, Inflammatory Bowel Disease, Cancer, Other Applications
• 9.3. Global C-Reactive Protein Testing Market, Segmentation By End Use, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Clinics, Hospitals, Diagnostic Laboratories
• 9.4. Global C-Reactive Protein Testing Market, Sub-Segmentation Of Enzyme-Linked Immunosorbent Assay (ELISA), By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Direct ELISA, Indirect ELISA, Sandwich ELISA
• 9.5. Global C-Reactive Protein Testing Market, Sub-Segmentation Of Chemiluminescence Immunoassay (CLIA), By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Luminometer-Based CLIA, Automated CLIA Systems
• 9.6. Global C-Reactive Protein Testing Market, Sub-Segmentation Of Immunoturbidimetric Assays, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Nephelometry-Based Immunoturbidimetric Assays, Latex Agglutination Immunoturbidimetric Assays

10. C-Reactive Protein Testing Market Regional And Country Analysis

• 10.1. Global C-Reactive Protein Testing Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• 10.2. Global C-Reactive Protein Testing Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific C-Reactive Protein Testing Market

• 11.1. Asia-Pacific C-Reactive Protein Testing Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 11.2. Asia-Pacific C-Reactive Protein Testing Market, Segmentation By Assay Type, Segmentation By Application, Segmentation By End Use, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China C-Reactive Protein Testing Market

• 12.1. China C-Reactive Protein Testing Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 12.2. China C-Reactive Protein Testing Market, Segmentation By Assay Type, Segmentation By Application, Segmentation By End Use, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India C-Reactive Protein Testing Market

• 13.1. India C-Reactive Protein Testing Market, Segmentation By Assay Type, Segmentation By Application, Segmentation By End Use, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan C-Reactive Protein Testing Market

• 14.1. Japan C-Reactive Protein Testing Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 14.2. Japan C-Reactive Protein Testing Market, Segmentation By Assay Type, Segmentation By Application, Segmentation By End Use, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia C-Reactive Protein Testing Market

• 15.1. Australia C-Reactive Protein Testing Market, Segmentation By Assay Type, Segmentation By Application, Segmentation By End Use, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia C-Reactive Protein Testing Market

• 16.1. Indonesia C-Reactive Protein Testing Market, Segmentation By Assay Type, Segmentation By Application, Segmentation By End Use, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea C-Reactive Protein Testing Market

• 17.1. South Korea C-Reactive Protein Testing Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 17.2. South Korea C-Reactive Protein Testing Market, Segmentation By Assay Type, Segmentation By Application, Segmentation By End Use, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Taiwan C-Reactive Protein Testing Market

• 18.1. Taiwan C-Reactive Protein Testing Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 18.2. Taiwan C-Reactive Protein Testing Market, Segmentation By Assay Type, Segmentation By Application, Segmentation By End Use, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. South East Asia C-Reactive Protein Testing Market

• 19.1. South East Asia C-Reactive Protein Testing Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 19.2. South East Asia C-Reactive Protein Testing Market, Segmentation By Assay Type, Segmentation By Application, Segmentation By End Use, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Western Europe C-Reactive Protein Testing Market

• 20.1. Western Europe C-Reactive Protein Testing Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 20.2. Western Europe C-Reactive Protein Testing Market, Segmentation By Assay Type, Segmentation By Application, Segmentation By End Use, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. UK C-Reactive Protein Testing Market

• 21.1. UK C-Reactive Protein Testing Market, Segmentation By Assay Type, Segmentation By Application, Segmentation By End Use, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Germany C-Reactive Protein Testing Market

• 22.1. Germany C-Reactive Protein Testing Market, Segmentation By Assay Type, Segmentation By Application, Segmentation By End Use, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. France C-Reactive Protein Testing Market

• 23.1. France C-Reactive Protein Testing Market, Segmentation By Assay Type, Segmentation By Application, Segmentation By End Use, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Italy C-Reactive Protein Testing Market

• 24.1. Italy C-Reactive Protein Testing Market, Segmentation By Assay Type, Segmentation By Application, Segmentation By End Use, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Spain C-Reactive Protein Testing Market

• 25.1. Spain C-Reactive Protein Testing Market, Segmentation By Assay Type, Segmentation By Application, Segmentation By End Use, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Eastern Europe C-Reactive Protein Testing Market

• 26.1. Eastern Europe C-Reactive Protein Testing Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 26.2. Eastern Europe C-Reactive Protein Testing Market, Segmentation By Assay Type, Segmentation By Application, Segmentation By End Use, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Russia C-Reactive Protein Testing Market

• 27.1. Russia C-Reactive Protein Testing Market, Segmentation By Assay Type, Segmentation By Application, Segmentation By End Use, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. North America C-Reactive Protein Testing Market

• 28.1. North America C-Reactive Protein Testing Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 28.2. North America C-Reactive Protein Testing Market, Segmentation By Assay Type, Segmentation By Application, Segmentation By End Use, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. USA C-Reactive Protein Testing Market

• 29.1. USA C-Reactive Protein Testing Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 29.2. USA C-Reactive Protein Testing Market, Segmentation By Assay Type, Segmentation By Application, Segmentation By End Use, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Canada C-Reactive Protein Testing Market

• 30.1. Canada C-Reactive Protein Testing Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 30.2. Canada C-Reactive Protein Testing Market, Segmentation By Assay Type, Segmentation By Application, Segmentation By End Use, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. South America C-Reactive Protein Testing Market

• 31.1. South America C-Reactive Protein Testing Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 31.2. South America C-Reactive Protein Testing Market, Segmentation By Assay Type, Segmentation By Application, Segmentation By End Use, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Brazil C-Reactive Protein Testing Market

• 32.1. Brazil C-Reactive Protein Testing Market, Segmentation By Assay Type, Segmentation By Application, Segmentation By End Use, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Middle East C-Reactive Protein Testing Market

• 33.1. Middle East C-Reactive Protein Testing Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 33.2. Middle East C-Reactive Protein Testing Market, Segmentation By Assay Type, Segmentation By Application, Segmentation By End Use, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Africa C-Reactive Protein Testing Market

• 34.1. Africa C-Reactive Protein Testing Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 34.2. Africa C-Reactive Protein Testing Market, Segmentation By Assay Type, Segmentation By Application, Segmentation By End Use, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. C-Reactive Protein Testing Market Regulatory and Investment Landscape

36. C-Reactive Protein Testing Market Competitive Landscape And Company Profiles

• 36.1. C-Reactive Protein Testing Market Competitive Landscape And Market Share 2024
  • 36.1.1. Top 10 Companies (Ranked by revenue/share)
• 36.2. C-Reactive Protein Testing Market - Company Scoring Matrix
  • 36.2.1. Market Revenues
  • 36.2.2. Product Innovation Score
  • 36.2.3. Brand Recognition
• 36.3. C-Reactive Protein Testing Market Company Profiles
  • 36.3.1. Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 36.3.2. F Hoffmann-La Roche AG Overview, Products and Services, Strategy and Financial Analysis
  • 36.3.3. Danaher Corporation Overview, Products and Services, Strategy and Financial Analysis
  • 36.3.4. Quest Diagnostics Incorporated Overview, Products and Services, Strategy and Financial Analysis
  • 36.3.5. Siemens AG Overview, Products and Services, Strategy and Financial Analysis

37. C-Reactive Protein Testing Market Other Major And Innovative Companies

• Abbott Laboratories, Aidian Oy, Boditech Med Inc., Horiba Ltd., Laboratory Corporation, Merck KGAA, Randox Laboratories Limited, Getein Biotech Inc., Bio-Rad Laboratories Inc., DiaSorin S.p.A., Eurofins Scientific SE, Inova Diagnostics Inc., Luminex Corporation, Sekisui Diagnostics LLC, Sysmex Corporation

38. Global C-Reactive Protein Testing Market Competitive Benchmarking And Dashboard

39. Key Mergers And Acquisitions In The C-Reactive Protein Testing Market

40. C-Reactive Protein Testing Market High Potential Countries, Segments and Strategies

• 40.1 C-Reactive Protein Testing Market In 2030 - Countries Offering Most New Opportunities
• 40.2 C-Reactive Protein Testing Market In 2030 - Segments Offering Most New Opportunities
• 40.3 C-Reactive Protein Testing Market In 2030 - Growth Strategies
  • 40.3.1 Market Trend Based Strategies
  • 40.3.2 Competitor Strategies

41. Appendix

• 41.1. Abbreviations
• 41.2. Currencies
• 41.3. Historic And Forecast Inflation Rates
• 41.4. Research Inquiries
• 41.5. The Business Research Company
• 41.6. Copyright And Disclaimer